State-of-the-Art Paper
Clinical and Mechanistic Issues in Early Repolarization: Of Normal Variants and Lethal Arrhythmia Syndromes

https://doi.org/10.1016/j.jacc.2010.05.037Get rights and content
Under an Elsevier user license
open archive

Early repolarization, involving ST-segment elevation and, sometimes, prominent J waves at the QRS-ST junction, has been considered a normal electrocardiographic variant for over 60 years. A growing number of case reports and case-control studies indicate that in some instances, early repolarization patterns are associated with increased risk of idiopathic ventricular fibrillation. Epidemiological evidence indicates a dose effect for the risk of cardiac and sudden death with the extent of J-point elevation. This paper reviews present knowledge regarding the epidemiology, presentation, therapeutic response, and mechanisms characteristic of early repolarization. We highlight major unanswered questions relating to our limited ability to determine which individuals with this common electrocardiographic variant are at risk for sudden death, our incomplete understanding of underlying mechanisms, the inadequate information regarding genetic determinants and therapeutic responses, and the unclear relationship between early repolarization and other conditions involving accelerated repolarization and sudden arrhythmic death such as Brugada and short-QT syndromes. This review paper intends to inform the practicing physician about important clinical issues and to stimulate investigators to address the many unresolved questions in this rapidly evolving field.

Key Words

early repolarization
idiopathic ventricular fibrillation
sudden cardiac death

Abbreviations and Acronyms

AP
action potential
BrS
Brugada syndrome
ECG
electrocardiogram
ER
early repolarization
ICD
implantable cardioverter-defibrillator
Ito
transient outward current
IVF
idiopathic ventricular fibrillation
SCD
sudden cardiac death
SQTS
short-QT syndrome
VF
ventricular fibrillation

Cited by (0)

Supported by Canadian Institutes of Health Research (MOP 68929), Leducq Foundation (07/CVD/03), Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica, Instituto de Salud Carlos III/FIS (CM06/00189 and CM08/00201), and Fundación Alfonso Martín Escudero. The authors have reported that they have no other individual relationships to disclose. Drs. Benito and Guasch contributed equally to this paper.